Browsing by Author "Peindl, Kathleen S"
Now showing items 1-4 of 4
-
Buprenorphine-mediated transition from opioid agonist to antagonist treatment: state of the art and new perspectives.
(Current drug abuse reviews, 2012-03)Constant refinement of opioid dependence (OD) therapies is a condition to promote treatment access and delivery. Among other applications, the partial opioid agonist buprenorphine has been studied to improve evidence-based ... -
Extended release naltrexone injection is performed in the majority of opioid dependent patients receiving outpatient induction: a very low dose naltrexone and buprenorphine open label trial.
(Drug and alcohol dependence, 2014-05)The approval of extended release injectable naltrexone (XR-NTX; Vivitrol(®)) has introduced a new option for treating opioid addiction, but studies are needed to identify its place within the spectrum of available therapies. ... -
Pharmacological enhancement of naltrexone treatment for opioid dependence: a review.
(Subst Abuse Rehabil, 2011-06)PURPOSE: Opioid dependence (OD) is a serious and growing clinical condition with increasing social costs that requires expanding treatment beyond opioid agonist substitution. The opioid antagonist naltrexone has displayed ... -
Smoking and opioid detoxification: behavioral changes and response to treatment.
(Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2013-10)The relevance of tobacco use in opioid addiction (OA) has generated a demand for available and more effective interventions. Thus, further analysis of less explored nicotine-opioid clinical interactions is warranted.A post-hoc ...
